Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1146320130010010027
Journal of Health Technology Assessment
2013 Volume.1 No. 1 p.27 ~ p.42
Ongoing Measures to Enhance Prescribing Efficiency Across Europe: Implications for Other Countries
Godman Brian

Campbell Stephen
Suh Hae-Sun
Finlayson Alexander E
Bennie Marion
Gustafsson Lars L
Abstract
Objectives: Pharmaceutical expenditure has risen rapidly resulting in multiple reforms across countries. This includes Korea. Review policies and initiatives undertaken in Europe to improve the quality and efficiency of prescribing of both new and established drugs to provide guidance.

Methods: Principally a narrative review of papers.

Results: New models have been developed to optimise the managed entry of new drugs centring on three pillars of pre-, peri-, and post-launch activities. Scrutiny of prices of new drugs will increase given typically their limited health gain and high requested prices. Successful measures have enhanced the prescribing of low cost generics versus originators and patent products in a class releasing considerable resources. In addition, improve the quality of care through high adherence to an essential medicine list.

Conclusion: We hope by providing details of reforms across Europe, and their influence, we have stimulated debate in Korea regarding potential measures to consider in the future.
KEYWORD
Demand-side measures, Introduction new drugs, PPIs, Renin-angiotensin inhibitor drugs, Statins, Supply-side measures
FullTexts / Linksout information
Listed journal information